ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
82,115
0,16%
Bitcoin
69 095,25
0,85%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. RegeneRX Biopharmaceuticals Inc (CE) (RGRX)

  7. RegeneRX Biopharmaceuticals Inc (CE) (RGRX) Actualités

RGRX

RegeneRX Biopharmaceutic... (CE) (RGRX)

RegeneRX Biopharmaceuticals Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:RGRX
DateHeureSourceTitreSymboleSociété
14/08/202322h01Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/08/202321h57Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/07/202323h13Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202322h35Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
06/07/202322h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
26/06/202312h01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
21/06/202312h03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
15/05/202322h25Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
11/04/202322h32Edgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/05/202223h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/10/202112h05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
17/08/202116h32Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
19/07/202122h16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
09/02/202100h29Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
16/10/202022h17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
18/08/202012h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
10/09/201923h06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
07/03/201920h15Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/03/201922h42Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
24/10/201812h02Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
23/10/201812h05Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
12/12/201718h35Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
14/08/201723h10Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
03/08/201612h03Edgar (US Regulatory)(DEL AM)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
30/03/201623h17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
29/12/201419h42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422h43Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422h43Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422h42Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
01/04/201422h37Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:RGRX

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
EU
AF
Air FranceKLM
EU
VK
Vallourec
EU
BEL20
Bel 20
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
NKE
Nike
EU
GLE
Societe Generale
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
EU
PX1
CAC 40
EU
RI
Pernod Ricard
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés